| A program for relapse prevention in schizophrenia: a controlled study MI Herz, JS Lamberti, J Mintz, R Scott, SP O'Dell, L McCartan, G Nix Archives of general psychiatry 57 (3), 277-283, 2000 | 393 | 2000 |
| Forensic assertive community treatment: Preventing incarceration of adults with severe mental illness JS Lamberti, R Weisman, DI Faden Psychiatric Services 55 (11), 1285-1293, 2004 | 269 | 2004 |
| Prevalence of the metabolic syndrome among patients receiving clozapine JS Lamberti, D Olson, JF Crilly, T Olivares, GC Williams, X Tu, W Tang, ... American Journal of Psychiatry 163 (7), 1273-1276, 2006 | 262 | 2006 |
| Weight gain among schizophrenic patients treated with clozapine. JS Lamberti, T Bellnier, SB Schwarzkopf The American journal of psychiatry 149 (5), 689-690, 1992 | 228 | 1992 |
| A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia DC Goff, JS Lamberti, AC Leon, MF Green, AL Miller, J Patel, ... Neuropsychopharmacology 33 (3), 465-472, 2008 | 225 | 2008 |
| Understanding and preventing criminal recidivism among adults with psychotic disorders JS Lamberti Psychiatric Services 58 (6), 773-781, 2007 | 202 | 2007 |
| Effectiveness of paliperidone palmitate vs haloperidol decanoate for maintenance treatment of schizophrenia: a randomized clinical trial JP McEvoy, M Byerly, RM Hamer, R Dominik, MS Swartz, RA Rosenheck, ... Jama 311 (19), 1978-1987, 2014 | 198 | 2014 |
| Randomized multicenter investigation of folate plus vitamin B12 supplementation in schizophrenia JL Roffman, JS Lamberti, E Achtyes, EA Macklin, GC Galendez, ... JAMA psychiatry 70 (5), 481-489, 2013 | 182 | 2013 |
| The mentally ill in jails and prisons: Towards an integrated model of prevention JS Lamberti, RL Weisman, SB Schwarzkopf, N Price, RM Ashton, ... Psychiatric Quarterly 72, 63-77, 2001 | 180 | 2001 |
| Concurrent assessment of acoustic startle and auditory P50 evoked potential measures of sensory inhibition SB Schwarzkopf, JS Lamberti, DA Smith Biological psychiatry 33 (11-12), 815-828, 1993 | 166 | 1993 |
| Practice guideline for the treatment of patients with schizophrenia MI Herz, RP Liberman, TH McGlashan, JA Lieberman, RJ Wyatt, ... American Journal of Psychiatry 154 (4 SUPPL.), 1-63, 1997 | 145 | 1997 |
| Variations in mental health courts: Challenges, opportunities, and a call for caution SK Erickson, A Campbell, J Steven Lamberti Community mental health journal 42, 335-344, 2006 | 107 | 2006 |
| Integrating criminal justice, community healthcare, and support services for adults with severe mental disorders RL Weisman, JS Lamberti, N Price Psychiatric Quarterly 75, 71-85, 2004 | 102 | 2004 |
| Prodromal symptoms and relapse prevention in schizophrenia MI Herz, JS Lamberti Schizophrenia Bulletin 21 (4), 541-551, 1995 | 96 | 1995 |
| Prevalence of diabetes mellitus among outpatients with severe mental disorders receiving atypical antipsychotic drugs JS Lamberti, JF Crilly, K Maharaj, D Olson, K Wiener, S Dvorin, ... Journal of Clinical Psychiatry 65, 702-706, 2004 | 92 | 2004 |
| Preventing criminal recidivism through mental health and criminal justice collaboration JS Lamberti Psychiatric Services 67 (11), 1206-1212, 2016 | 86 | 2016 |
| Racial disparities in the use of second-generation antipsychotics for the treatment of schizophrenia JB Mallinger, SG Fisher, T Brown, JS Lamberti Psychiatric services 57 (1), 133-136, 2006 | 81 | 2006 |
| Persons with severe mental disorders in the criminal justice system: Challenges and opportunities JS Lamberti, RL Weisman Psychiatric Quarterly 75, 151-164, 2004 | 80 | 2004 |
| Determining when impairment constitutes incapacity for informed consent in schizophrenia research SYH Kim, PS Appelbaum, J Swan, TS Stroup, JP McEvoy, DC Goff, ... The British Journal of Psychiatry 191 (1), 38-43, 2007 | 74 | 2007 |
| Meeting health and psychological needs of women in drug treatment court DS Morse, C Cerulli, P Bedell, JL Wilson, K Thomas, M Mittal, JS Lamberti, ... Journal of Substance Abuse Treatment 46 (2), 150-157, 2014 | 66 | 2014 |
